Ablynx Wins E1.8 Million Grant From IWT
Ablynx, a biopharmaceutical company focused on the discovery and development of nanobodies, has received a grant worth E1.8 million from the Institute for the Promotion of Innovation by Science and Technology in Flanders.
The grant, which is over three years, allows Ablynx to further develop technologies related to its Nanobody platform. Furthermore, this grant will enable Ablynx to expand its intellectual property portfolio.
Edwin Moses, CEO and chairman of Ablynx, said: “We are extremely pleased to receive another grant from Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT) and for their continued support of Ablynx’s Nanobody technology platform.
“We believe this grant will allow us to dedicate a focused effort to look at novel technologies for our therapeutic nanobodies and add even further value to an already growing product portfolio.”